Ledger.Open graph →

SEC Form D · filed July 29, 2022

VITARA BIOMEDICAL, INC

Offering

$75.0M

Sold

$25.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PHILADELPHIA, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

James Mcglone · Philadelphia, PAExec · Director Ian Ratcliffe · Philadelphia, PADirector John Kelly · Philadelphia, PAExec Ted Fjallman · Philadelphia, PADirector Diem Nguyen · Philadelphia, PADirector Thomas Todorow · Philadelphia, PADirector Bernard Lyons · Philadelphia, PADirector Rosaleen Oskanian · Philadelphia, PAExec Bernard A. Fox, Iii · Portland, ORDirector John Krambeer · El Segundo, CAExec Xiaorui Bao · HONG KONG, Hong KongExec · Director Michael Phipps · Charlotte, NCDirector Wayne Grube, Jr · Baltimore, MDDirector Fei Wu · HONG KONG, Hong KongDirector Chris Abraham · Chicago, ILExec Rishi Malhotra · New York, NYDirector Monash Kothari · Philadelphia, PADirector Steven W. Gfroerer · Waukee, IAExec Kari J. Cooling · Waukee, IAExec John C. Goff · FORT WORTH, TXDirector Andrew P. Lombardi · FORT WORTH, TXDirector Carol Reynolds · Grand Cayman, Cayman IslandsDirector Gary Gladstein · Grand Cayman, Cayman IslandsExec · Director Dennis Hunter · Grand Cayman, Cayman IslandsDirector Reto Ringger · Zurich, V8Director Monash Kothari · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗